射血分数保留的心力衰竭患者中冠状动脉疾病与冠状动脉微血管功能障碍的患病率
这项前瞻性多中心队列研究纳入106例住院HFpEF患者,评估冠状动脉疾病和微血管功能障碍的患病率。结果显示91%的患者存在心外膜冠状动脉疾病、微血管功能障碍或两者兼有;在无阻塞性心外膜冠状动脉疾病的患者中,81%存在微血管功能障碍。阻塞性心外膜冠状动脉疾病和微血管功能障碍在住院HFpEF患者中常见且常被漏诊,可能成为治疗靶点。
要点
- 住院HFpEF患者中91%存在心外膜冠状动脉疾病、微血管功能障碍或两者兼有。
- 无阻塞性心外膜冠状动脉疾病的患者中81%存在微血管功能障碍。
- 阻塞性心外膜冠状动脉疾病患者随访不良事件更多(74% vs 46%)。
核心结论
- 住院HFpEF患者中91%存在心外膜冠状动脉疾病、微血管功能障碍或两者兼有,其中无阻塞性心外膜冠状动脉疾病者81%存在微血管功能障碍。
研究设计与样本
- 前瞻性多中心队列研究,纳入106例连续住院HFpEF患者(53例女性,平均年龄72岁)。
- 患者接受冠状动脉造影及导丝评估冠状动脉血流储备、微血管阻力指数和血流储备分数,随后行冠状动脉血管反应性测试。
- 部分患者接受心脏磁共振成像及晚期钆增强和细胞外容积评估,心肌灌注采用心肌灌注储备指数定性及半定量评估。
主要发现
- 阻塞性心外膜冠状动脉疾病存在于38/75例(51%,95%CI 39%-62%),其中19/38例(50%,95%CI 34%-66%)无冠状动脉疾病史。
- 内皮非依赖性微血管功能障碍(冠状动脉血流储备<2.0和/或微血管阻力指数≥25)见于41/62例(66%,95%CI 53%-77%)。
- 内皮依赖性微血管功能障碍(冠状动脉血管反应性异常)见于10/41例(24%,95%CI 13%-40%)。
- 总体45/53例(85%,95%CI 72%-92%)有微血管功能障碍证据,无阻塞性心外膜冠状动脉疾病者中29/36例(81%,95%CI 64%-91%)有微血管功能障碍。
- 心脏磁共振显示心肌灌注储备指数≤1.84(整体心肌灌注受损)见于29/41例(71%,95%CI 54%-83%),视觉灌注缺损见于14/46例(30%,95%CI 19%-46%),缺血性晚期钆增强(心肌梗死)见于14/52例(27%,95%CI 16%-41%),细胞外容积>30%(弥漫性心肌纤维化)见于20/48例(42%,95%CI 28%-56%)。
关键数值与推荐
- 内皮非依赖性微血管功能障碍定义为冠状动脉血流储备<2.0和/或微血管阻力指数≥25。
- 内皮依赖性微血管功能障碍定义为冠状动脉血管反应性异常。
- 整体心肌灌注受损定义为心肌灌注储备指数≤1.84。
- 弥漫性心肌纤维化定义为细胞外容积>30%。
临床怎么用
- 住院HFpEF患者应评估阻塞性心外膜冠状动脉疾病和微血管功能障碍,二者常见且常被漏诊。
- 无阻塞性心外膜冠状动脉疾病的HFpEF患者仍应警惕微血管功能障碍。
- 阻塞性心外膜冠状动脉疾病和微血管功能障碍可能成为HFpEF的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Coronary artery disease (CAD) and coronary microvascular dysfunction (CMD) may contribute to the pathophysiologic characteristics of heart failure with preserved ejection fraction (HFpEF). However, the prevalence of CAD and CMD have not been systematically studied. OBJECTIVE: To examine the prevalence of CAD and CMD in hospitalized patients with HFpEF. DESIGN, SETTING, AND PARTICIPANTS: A total of 106 consecutive patients hospitalized with HFpEF were evaluated in this prospective, multicenter, cohort study conducted between January 2, 2017, and August 1, 2018; data analysis was performed from March 4 to September 6, 2019. Participants underwent coronary angiography with guidewire-based assessment of coronary flow reserve, index of microvascular resistance, and fractional flow reserve, followed by coronary vasoreactivity testing. Cardiac magnetic resonance imaging was performed with late gadolinium enhancement and assessment of extracellular volume. Myocardial perfusion was assessed qualitatively and semiquantitatively using the myocardial-perfusion reserve index. MAIN OUTCOMES AND MEASURES: The prevalence of obstructive epicardial CAD, CMD, and myocardial ischemia, infarction, and fibrosis. RESULTS: Of 106 participants enrolled (53 [50%] women; mean [SD] age, 72 [9] years), 75 had coronary angiography, 62 had assessment of coronary microvascular function, 41 underwent coronary vasoreactivity testing, and 52 received cardiac magnetic resonance imaging. Obstructive epicardial CAD was present in 38 of 75 participants (51%, 95% CI, 39%-62%); 19 of 38 (50%; 95% CI, 34%-66%) had no history of CAD. Endothelium-independent CMD (ie, coronary flow reserve <2.0 and/or index of microvascular resistance ≥25) was identified in 41 of 62 participants (66%; 95% CI, 53%-77%). Endothelium-dependent CMD (ie, abnormal coronary vasoreactivity) was identified in 10 of 41 participants (24%; 95% CI, 13%-40%). Overall, 45 of 53 participants (85%; 95% CI, 72%-92%) had evidence of CMD and 29 of 36 (81%; 95% CI, 64%-91%) of those without obstructive epicardial CAD had CMD. Cardiac magnetic resonance imaging findings included myocardial-perfusion reserve index less than or equal to 1.84 (ie, impaired global myocardial perfusion) in 29 of 41 patients (71%; 95% CI, 54%-83%), visual perfusion defect in 14 of 46 patients (30%; 95% CI, 19%-46%), ischemic late gadolinium enhancement (ie, myocardial infarction) in 14 of 52 patients (27%; 95% CI, 16%-41%), and extracellular volume greater than 30% (ie, diffuse myocardial fibrosis) in 20 of 48 patients (42%; 95% CI, 28%-56%). Patients with obstructive CAD had more adverse events during follow-up (28 [74%]) than those without obstructive CAD (17 [46%]). CONCLUSIONS AND RELEVANCE: In this cohort study, 91% of patients with HFpEF had evidence of epicardial CAD, CMD, or both. Of those without obstructive CAD, 81% had CMD. Obstructive epicardial CAD and CMD appear to be common and often unrecognized in hospitalized patients with HFpEF and may be therapeutic targets.
引用
- Rush CJ, Berry C, Oldroyd KG, et al. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021. PMID: 34160566. doi:10.1001/jamacardio.2021.1825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。